Truist Securities Reiterates Hold on Inspire Medical Systems, Lowers Price Target to $76
Truist Securities analyst Richard Newitter reiterates Inspire Medical Systems (NYSE:INSP) with a Hold and lowers the price target from $78 to $76.
Share
Why It Matters
An expert analyst thinks Inspire Medical will stay about the same price. They lowered their guess from $78 to $76, but still say to wait.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.